Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries internationally.

Based in the UK, the brand was launched in 2005 by Charles Rolls and Tim Warrillow to provide high quality, natural mixers which could accompany the growing demand for premium spirits. The Group now sells a range of 12 differentiated flavours to hotels, restaurants, bars and cafes ("On Trade") as well as supermarkets and off-licenses for retail purchase ("Off Trade"). Approximately 70 per cent. of the Group's sales were derived from outside of the UK in FY13 with the key overseas markets being the US, Spain, and Belgium.

The Group's mixers are designed to be accompaniments for alcoholic spirits or used in cocktails, although they can also be consumed on their own. Since 2005, the Company has launched at least one new product a year, which includes 4 variants of tonic water, 2 variants of ginger beer, 3 variants of lemonade, and one variant each of ginger ale, soda water and cola.

7 November 2014
Admission to AIM and first day of dealings


http://www.fever-tree.com/

Blind as a bat these days, I put it down to far to many holidays.

Buyer or Seller from here?

I think major competitors may pounce if there is a major share price weakness, on a not up to expectation set of results . Just puzzles me as to why they have not been taken out already ? I personally would not buy now as they could disappoint the market at some stage, cannot keep growing. But then again they might, who knows. :-))

Lots of profit taking?

i really don't know ..... there's seems no fundamental reason, so perhaps just stale bulls locking in profits and/or s/b holders being closed out ...... no news forthcoming

Second paragraph page 1?

a bit flimsy to account for FEVR's fall

Gap to fill from late July.

whatever .... but if it's bears, then they are getting their bums bitten as sp has now recovered from its low of 1945 to the current 2025 ...... though it opened at 2125

Mind the gap!

RBC Capital Markets today downgrades its investment rating on Fevertree Drinks Plc (LON:FEVR) to sector performer (from outperform) and cut its price target to 2000p (from 2400p).

was just about to post that :-)

Never rated this lot anyway 😀

no doubt because you never bought them

exactly so skinny ..... bounce from 200 sma; you'ld have to have moved fast and bravely to catch at the bottom though

though restaurant and pub figures may be down, don't forget that FEVR has a lot of other exposure through the supermarkets and even airlines

Sharecast -

RBC slashes Fevertree target price on competitive threat from Schweppes




FEVERTREE DRINKS
1,911.00
16:35:24 02/11/17
-5.63%
-114.00
Analysts at RBC Capital Markets slashed their target price on shares of Fevertree ahead of the re-launch of Schweppes's more premium 1783 brand and in light of the recent acceleration in the rate of organic growth in the company's sales in the UK market to over 60% since the backhalf of 2016.
They conceded the company's "strong execution" and the "extraordinary" performance of its premium gin category but were wary of reports that Schweppes was set to make the largest ever investment - roughly £6.6m according to Marketing Week - in the above brand.
Somewhat ironically too, Fevertree's success meant its growth profile was also more exposed to such a threat, what with sales in Britain expected to account for 45% of the total in fiscal year 2017 for a market share of 30%.
Hence, RBC lowered its projections for the company's rate of organic sales growth between 2017 to 2019 in the UK from 60%, 20% and 14% to 50%, 10% and 10%, respectively.
In turn, organic group sales were now seen rising by 44%,. 19% and 18%, down from 49%, 24% and 19%, respectively.
The broker also trimmed its estimates for the group's EBIT margins for the next three years by 50 basis points as a result of its forecasts for increased spending in advertising and publicity in the UK market.
All told, the result of those revisions drove its target price down from 2,400p to 2,000p and resulted in the analysts downgrading their recommendation on the stock from 'outperform' to 'sector perform'.

Looks like Schweppes are going to take them on with their own brand, opposed to a buy out.

536. Lack of sense of humour alert!